Jupiter Topco LLC Takes $6.22 Million Position in Globe Life Inc. $GL

Jupiter Topco LLC purchased a new position in shares of Globe Life Inc. (NYSE:GL) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 34,767 shares of the company’s stock, valued at approximately $6,217,000.

Several other hedge funds have also made changes to their positions in GL. Compound Planning Inc. grew its stake in Globe Life by 4.3% during the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after buying an additional 82 shares during the last quarter. Root Financial Partners LLC lifted its stake in Globe Life by 23.3% in the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after buying an additional 83 shares during the last quarter. Parallel Advisors LLC boosted its holdings in shares of Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after acquiring an additional 87 shares during the period. First United Bank & Trust boosted its holdings in shares of Globe Life by 2.1% during the first quarter. First United Bank & Trust now owns 4,355 shares of the company’s stock valued at $606,000 after acquiring an additional 90 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in shares of Globe Life by 4.0% during the first quarter. EverSource Wealth Advisors LLC now owns 2,366 shares of the company’s stock worth $329,000 after acquiring an additional 91 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Globe Life Trading Down 0.1%

Shares of GL opened at $172.59 on Tuesday. The business’s 50-day moving average price is $178.78 and its 200 day moving average price is $159.87. The stock has a market capitalization of $13.26 billion, a P/E ratio of 11.46 and a beta of 0.48. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 1-year low of $127.85 and a 1-year high of $191.55.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the prior year, the company posted $3.05 earnings per share. The firm’s revenue was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Analysts expect that Globe Life Inc. will post 15.71 earnings per share for the current year.

Globe Life declared that its Board of Directors has approved a share repurchase plan on Monday, August 10th that permits the company to repurchase $2.50 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 17.7% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Globe Life Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s dividend payout ratio is 8.76%.

Insider Buying and Selling at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 21,000 shares of the stock in a transaction that occurred on Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the completion of the sale, the chief financial officer owned 50,568 shares in the company, valued at $9,105,274.08. This represents a 29.34% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Cheryl Alston sold 8,258 shares of the stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the completion of the sale, the director owned 16,621 shares of the company’s stock, valued at approximately $2,979,148.04. The trade was a 33.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 151,908 shares of company stock valued at $27,239,981 in the last 90 days. Corporate insiders own 2.11% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on GL. Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. Jefferies Financial Group upped their target price on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. JPMorgan Chase & Co. raised their price target on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Keefe, Bruyette & Woods cut their price target on Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. Finally, Wells Fargo & Company boosted their price objective on Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research report on Thursday, July 9th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $191.67.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.